Daraxonrasib doubles survival — a RAS‑targeting drug development breakthrough. Daraxonrasib doubled median survival versus ...

Companies see a commercial opportunity in creating new ways to administer drugs to patients – in space.

Critical Path Institute® (C-Path) will host its 2026 Global Impact Conference (CGIC) this September at the Washington ...

AstraZeneca CEO Pascal Soriot said AI is helping the company develop medicines faster and make smarter decisions throughout ...

Snowflake (NYSE: SNOW), the AI Data Cloud company, today announced at Snowflake Summit 26 that Sanofi, one of the world's ...

Building on its legacy of standardizing LC separation, Evosep now extends upstream to sample preparation, delivering complete ...

Discover how quality-driven drug development and AI accelerate safer medicines, reduce risk, and improve patient outcomes.

In this week’s edition of InnovationRx, we look at a new AI drug development deal, a pill for sleep apnea, Commure’s $7 ...

Big Pharma is pouring money into tech-devised treatments, but the verdict is out on whether they’ll actually work.

There has been much discussion recently about how artificial intelligence and machine learning (AI/ML) will revolutionize pharmaceutical research. Substantial progress has been made in the discovery ...

Jindal served as governor of Louisiana and as a U.S. assistant secretary of Health and Human Services. Katebi is deputy director of the Center for a Healthy America at the America First Policy ...

A drug once dismissed as ineffective suddenly worked — when scientists tested it under more realistic conditions that mimic the human body. In this surprising new discovery, Northwestern University ...